As of 2025-11-24, the Relative Valuation of Bioatla Inc (BCAB) is (38.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.86 USD, the upside of Bioatla Inc based on Relative Valuation is -4570.7%.
The range of the Relative Valuation is (33.91) - (37.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 24.1x | 21.6x |
| Forward P/E multiples | 21.7x - 32.9x | 27.3x |
| Fair Price | (33.91) - (37.70) | (38.32) |
| Upside | -4056.5% - -4498.5% | -4570.7% |
| Date | P/E |
| 2025-11-21 | -0.56 |
| 2025-11-20 | -0.74 |
| 2025-11-19 | -0.74 |
| 2025-11-18 | -0.78 |
| 2025-11-17 | -0.65 |
| 2025-11-14 | -0.50 |
| 2025-11-13 | -0.42 |
| 2025-11-12 | -0.44 |
| 2025-11-11 | -0.44 |
| 2025-11-10 | -0.41 |
| 2025-11-07 | -0.44 |
| 2025-11-06 | -0.41 |
| 2025-11-05 | -0.41 |
| 2025-11-04 | -0.43 |
| 2025-11-03 | -0.42 |
| 2025-10-31 | -0.45 |
| 2025-10-30 | -0.44 |
| 2025-10-29 | -0.45 |
| 2025-10-28 | -0.47 |
| 2025-10-27 | -0.45 |
| 2025-10-24 | -0.49 |
| 2025-10-23 | -0.46 |
| 2025-10-22 | -0.42 |
| 2025-10-21 | -0.44 |
| 2025-10-20 | -0.39 |
| 2025-10-17 | -0.53 |
| 2025-10-16 | -0.47 |
| 2025-10-15 | -0.53 |
| 2025-10-14 | -0.51 |
| 2025-10-13 | -0.58 |
| 2025-10-10 | -0.55 |
| 2025-10-09 | -0.65 |
| 2025-10-08 | -0.58 |
| 2025-10-07 | -0.51 |
| 2025-10-06 | -0.52 |
| 2025-10-03 | -0.44 |
| 2025-10-02 | -0.42 |
| 2025-10-01 | -0.43 |
| 2025-09-30 | -0.44 |
| 2025-09-29 | -0.44 |
| 2025-09-26 | -0.43 |
| 2025-09-25 | -0.40 |
| 2025-09-24 | -0.39 |
| 2025-09-23 | -0.37 |
| 2025-09-22 | -0.40 |
| 2025-09-19 | -0.40 |
| 2025-09-18 | -0.44 |
| 2025-09-17 | -0.43 |
| 2025-09-16 | -0.46 |
| 2025-09-15 | -0.44 |